Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Experts say the world's first malaria vaccine could be approved for use in 2015.
Reporting in PLOS Medicine, researchers found that for every 1,000 children who received the vaccine, an average of 800 cases of illness could be prevented.
And in continuing trials it went on to provide protection some 18 months after the injections were given.
Manufacturers GSK have now applied for regulatory approval - making this the first vaccine to reach this step.
Malaria affects millions of people worldwide and results in 800,000 deaths each year - the majority in children under five who live in sub-Saharan Africa.
http://www.bbc.co.uk/news/health-28541939
Reporting in PLOS Medicine, researchers found that for every 1,000 children who received the vaccine, an average of 800 cases of illness could be prevented.
And in continuing trials it went on to provide protection some 18 months after the injections were given.
Manufacturers GSK have now applied for regulatory approval - making this the first vaccine to reach this step.
Malaria affects millions of people worldwide and results in 800,000 deaths each year - the majority in children under five who live in sub-Saharan Africa.
http://www.bbc.co.uk/news/health-28541939